President & CEO
Cary Hagan joined Intrinsic in 2011 from Wright Medical, where he served as Senior Vice President, Commercial Operations, for Europe, Middle East and Africa. He began his career at Wright Medical in 1989 and advanced through a series of sales and marketing positions with increasing responsibility. As Senior Director of Biologics, Cary was pivotal in the rapid growth of Wrights Orthobiologics program from “point zero” to market segment leader. Later as Vice President Marketing, Global OrthoRecon, he oversaw a turnaround in Wright’s Hip and Knee growth rates to roughly two times the industry average.
Cary completed undergraduate at Westminster College in Fulton Missouri, with majors in both Business Administration & Economics. He later earned a Master’s in Business Administration at St. Louis University & Webster Universities, with a focus on International Business.
Founder and Executive Director
Prior to founding Intrinsic in 1999, Greg Lambrecht was a Vice President of Product Development & Marketing at Stryker, a global orthopedic implant company, where he directed the development and launch of numerous successful orthopedic implants. Greg also held various management positions in product and business development within Pfizer’s Medical Technology Group. The core of his career at Pfizer was implementing a process for inventing and developing new technologies that best met the needs of Pfizer’s physician customers worldwide.
Greg received a Bachelor of Science in Nuclear Engineering from the Massachusetts Institute of Technology in 1990 and returned to the same institution for a Masters Degree in Mechanical Engineering in 1993. Greg holds numerous patents in the fields of gynecology, general surgery, cardiology, and orthopedics.
Chief Operating Officer
Prior to joining Intrinsic in 2000, Jacob Einhorn was Director of Product Development for Nippon Stryker, the Japanese operating division of Stryker Corporation, a global medical device company focused on the orthopedic market, where Jacob was responsible for establishing Stryker’s first R&D presence in Asia.
Jacob received a Bachelor of Arts in Physics and Anthropology from the Johns Hopkins University in 1992. Following several years of consumer products research and consumer advocacy in Washington, DC, he received a Masters of Science in Mechanical Engineering from MIT in 1997. Jacob holds numerous patents in the field of orthopedics.
Chief Financial Officer
Prior to joining Intrinsic, Thomas Heer was Director of Finance & Controller with Karl Storz Endoskope, a global manufacturer and distributor of endoscopes, medical instruments and devices, where he led the finance and accounting functions of the flexible endoscope operations – Storz’s largest production facility outside of Germany – improving productivity and profitability during a period of tremendous growth.
Tom spent the previous 16 years in public accounting with Ernst & Young, including a 4 year ex-pat assignment in Stuttgart Germany. Tom received a Bachelor of Science in Accounting from Marist College in 1989 and earned the Certified Public Accountant (CPA) title in 1991.
Vice President Commercial Operations, Germany & Austria
David Halliday joined Intrinsic in 2012 from Stryker, where he served as Vice President Spine, Interventional Pain and Biotech as well as a member of the European Leadership Team. Prior to this he was Managing Director for Stryker Germany, Switzerland and Austria. David has a combined 17 years of experience in medical devices and implants, the majority of which spent with Stryker and Fresenius.
Through his career, he has progressed through sales and marketing roles in a variety of industries until he advanced to general management in 1995. David is experienced in business development, reorganization as well as merger and acquisitions and has a strong track record in building high performance teams and organisations.
Vice President Market Access, Health Economics & Reimbursement
Thomas Michal has over 2 decades of healthcare experience with an emphasis on market access, health economics, global reimbursement, and government relations. He is a recognized expert in coding, coverage, and payment initiatives in start-up environments, as well as enterprise-level biomedical firms. As a specialist in market access and early commercialization, Tom has been responsible for guiding company efforts in key global markets in an effort to drive innovative technology adoption. Prior to joining Intrinsic Therapeutics, Tom has held leadership positions with multi-national corporations, as well medical device start-ups – these organizations include: Smith & Nephew Endoscopy, Moximed Inc., Allina Health Systems, and Deloitte Consulting.
Tom completed his undergraduate work at the University of Massachusetts Amherst, obtaining a Bachelor of Science Degree. He later earned a Master’s in Business Administration from Rice University in Houston Texas, with a concentration in both Marketing and Finance.
Vice President Global Marketing
Ivo Scheepens joined Intrinsic in 2011 from Wright Medical, where he served as Vice President Marketing for Europe, Middle East, and Africa. He brings over 20 years of Sales and Marketing experience in the global orthopedic and spinal industry.
Ivo started his career with Sofamor Danek, later Medtronic Spine, where he has held a number of Sales and Marketing management positions both in Europe and in the United States. Ivo was part of Medtronic’s global Marketing team who developed and brought to market their Minimal Access Spine Technologies (MAST) platform.
Vice President Academic & Distribution Development
Kyriacos Spentzos joined Intrinsic in 2012 from OrthoMedical SA, where he served as Managing Director and Founding Partner managing 70 employees and an annual turnover of $30M from three specialized Business Units targeting innovative technologies in Orthopedics. He began his career at J&J Professional in 1993 and brings more than 20 years of Sales and Marketing experience in Orthopedics, Biologics, and Spine.
Kyriacos received a Bachelor of Science in Mechanical Engineering from Lafayette College in 1990 (Easton PA, USA) and a Master of Science in Biomedical Engineering from the University of Strathclyde in 1993 (Glasgow, Scotland).
Vice President of Clinical Affairs
Kelsey Miller-Torchia joined Intrinsic in 2011 from Impliant, where she served as their Marketing Manager overseeing their US IDE, and clinical trials in Brazil, Israel and Belgium. Kelsey brings with her over 17 years of global clinical trial experience in the spinal industry.
Kelsey started her career in academics with The Boston Spine Group at the renowned New England Baptist Hospital. There she developed and managed their patient registries as well as managed their investigator and IDE clinical trials. Kelsey has a BA in South East Asian Studies and Religion from Tufts University.
Vice President Research
Oscar Yeh joined Intrinsic in 2004 and was initially responsible for the pre-clinical evaluation of the Barricaid® in benchtop, cadaveric, and animal testing. He has held multiple roles within Intrinsic and is currently responsible for research efforts stemming from the clinical and radiographic data collected in the Barricaid randomized clinical trial.
Oscar joined Intrinsic from the University of California, Davis Medical Center where he collaborated on basic science research projects within the Orthopaedic Surgery department. Research efforts included the response of musculoskeletal tissues to mechanical loading through the use of animal models, biomechanical testing, histology, finite element analysis, and constitutive modeling.